Benzimidazole derivatives

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S217090, C514S218000, C514S249000, C514S322000, C514S394000, C540S470000, C540S480000, C540S575000, C540S603000, C544S349000, C544S370000, C546S199000, C548S306100

Reexamination Certificate

active

07125877

ABSTRACT:
This invention provides compounds which are represented by a general formula [I][in which X stands for hydrogen or halogen; B stands for halogen, cyano or optionally fluorine-substituted lower alkyl; D stands for a 3–10 membered aliphatic nitrogen-containing heterocyclic group; R3, R4and R5may be same or different, and each stands for hydrogen, lower alkyl optionally having substituent group(s) and the like; and a is 0 or 1]. These compounds exhibit high affinity to nociceptin receptors and whereby inhibit actions of nociceptin, and are useful as an analgesic, antiobestic, agent for ameliorating brain function, treating agents for Alzheimer's disease and dementia, and therapeutic agents for schizophrenia, neurodegenerative diseases, depression, diabetes insipidus, polyuria, hypotension and the like.

REFERENCES:
patent: 0 254 322 (1988-01-01), None
patent: 0 370 381 (1990-05-01), None
patent: 0 963 987 (1999-12-01), None
patent: 0 970 957 (2000-01-01), None
patent: 99/36421 (1999-07-01), None
patent: 99/59997 (1999-11-01), None
patent: 00/14067 (2000-03-01), None
patent: 00/27815 (2000-05-01), None
Shinkai et al. J.Med. Chem. vol. 43, p. 4667-4677 (2000).
Yamada et al. British Journla of Pharmacology, vol. 135, p. 323-332 (2002).
Meunier et al., Nature, 377, 532-534 (1995).
Levine et al., Society for Neuroscience, 22, 455 (1996).
Stratford et al., NeuroReport, 8, 423-426 (1997).
Sandin et al., European Journal of Neuroscience, 9, 194-197 (1997).
Murphy et al., Neuroscience, 75(1), 1-4 (1996).
Mogil et al., Neuroscience, 75(2), 333-337 (1996).
Kapusta et al., Life Sciences, 60(1), PL 15-21 (1997).
Gamusel et al., Life Sciences, 60(8), PL 141-145 (1997).
Jenck et al., Proceedings of National Academy of Sciences, 94, 14854-14858 (1997).
Ueda et al., Neuroscience Letters, 237, 136-138 (1997).
Manabe et al., Nature, 394 577-581 (1998).
Malin et al., Psychopharmacology, 151, 344-350 (2000).
Ueda et al., The Journal of Neuroscience, 20 7640-7647 (2000),.
Köster et al., Proceedings of National Academy of Sciences, 96, 10444-10449 (1999).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Benzimidazole derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Benzimidazole derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzimidazole derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3616696

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.